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Case Report

Malignant phyllodes tumor with extensive
lipomatous differentiation
Jeffrey Landy MD∗, Priya Johal MD, Alexander Sevrukov MD, Ida Teberian MD,
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Phyllodes tumors are uncommon neoplasms of the breast. Lipomatous differentiation of
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malignant phyllodes tumor is a rare stromal alteration of this fibroepithelial tumor, demon-
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strated as a fat-containing mass on imaging. We present the case of a 46-year-old woman
who was diagnosed with a malignant phyllodes tumor of the breast that demonstrated extensive lipomatous differentiation.
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Introduction

Case report

Phyllodes tumor is a rare fibroepithelial neoplasm of the
breast, more commonly seen in middle-aged women. The
most common presentation is that of a rapidly growing, palpable mass. Phyllodes tumors may be classified as benign, malignant, or borderline, a distinction which is largely made histologically based on the degree of nuclear atypia, tumor border, stromal cellularity, and mitotic activity. While Ductal carcinoma in situ (DCIS), Lobular carcinoma in situ (LCIS), or invasive cancers may arise from the epithelial component of phyllodes tumors, the stromal component may contain heterologous elements such as adipose tissue, cartilage, bone, skeletal
muscle, and fibrous tissue. Lipomatous differentiation within
a phyllodes tumor is an uncommon stromal alteration. Herein,
we present a case of malignant phyllodes tumor with extensive lipomatous differentiation in a 46-year-old woman.

A 46-year-old woman presented for a screening mammogram,
reporting a new lump in her upper outer left breast. Mammogram demonstrated a 35-mm fat-containing, oval mass with
circumscribed margins in the 3 o’clock left breast, 9 cm from
the nipple which corresponded to the palpable mass reported
by the patient (Figs. 1 and 2). Breast sonography revealed an
oval, parallel, hyperechoic mass in the left breast, corresponding to the mammographic finding and region of palpable concern (Figs. 3 and 4).
The patient underwent an ultrasound-guided core needle biopsy which showed fragments of fibroadipose tissue
containing multiple foci of hypercellular spindle cell proliferation associated with benign ducts and focal fat necrosis.
There was significant nuclear atypia and a few mitoses were
present. Immunohistochemical stains showed that the spin-
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Fig. 1 – Craniocaudal digital breast tomosynthesis view of
the left breast demonstrate a fat-containing, oval mass with
circumscribed margins.
dle cells were negative for CK5/6, p63, CAM5.2, SMA, desmin,
AE1/AE3, CD163, nuclear beta catenin, SMA, and CD34. The Ki67 proliferation index was high (estimated ˜40%-60%). A definitive pathologic diagnosis was precluded in this specimen, and
excision was recommended due to the presence of atypia, hypercellularity, and proliferation index (Fig. 5, 6 and 7).
Subsequent wire localization excisional biopsy was performed. Microscopic examination revealed a biphasic hypercellular lesion with both stromal and distorted glandular elements and extensive lipomatous differentiation. Although
mostly well circumscribed, some infiltration into the surrounding tissue was identified as well as nuclear atypia and an
increased mitotic rate (10 mitoses/High-power field (HPF)). The
diagnosis of malignant phyllodes tumor with lipomatous differentiation was made based on these findings. Fluorescence
in situ hybridization (FISH) was performed and was negative
for Mouse double minute 2 (MDM2), suggesting that the lipomatous component itself was not malignant (ie, liposarcoma).

Discussion
Phyllodes tumors often present as a firm, palpable, mobile
mass that demonstrates rapid growth often over a course
of just several weeks. Imaging typically demonstrates a circumscribed, high density mass with oval, round, or lobulated
shape. The mean size is 4-5 cm but can range from 1 to 20 cm.
Associated calcifications are rare [1].

Fig. 2 – Mediolateral oblique synthetic digital breast
tomosynthesis view of the left breast demonstrate a
fat-containing, oval mass with circumscribed margins.

Certain imaging features of a phyllodes tumor may suggest
malignancy. Partially obscured or indistinct tumor margins
are more often seen in malignant phyllodes tumors. Tumor
size of greater than 3 cm is associated with a higher likelihood
of malignancy [1]. MRI may demonstrate restricted diffusion,
suggestive of a malignant phyllodes tumor. Focal intralesional
cysts are more common in malignant phyllodes tumors and
are manifest on MRI by hyperintense slit-like spaces on
T2-weighted images. While washout enhancement kinetics
are suspicious for malignancy, up to 35% of the malignant
phyllodes tumors may demonstrate persistent enhancement
kinetics more typically associated with benignity [2].
Histologically, phyllodes tumors are biphasic, consisting
of a hypercellular stromal component and cleft-like spaces
lined by epithelium, often forming a leaflike pattern [3]. Sufficient sampling is necessary if the lesion appears ill defined
(approximately 1 section per centimeter) and the tumor is
classified based on the area of highest cellularity or floridity
[4]. The tumors are divided into benign, intermediate, and malignant patterns based on several histologic characteristics,
including an infiltrative margin, stromal overgrowth, mitotic
count, amount of hypercellularity, and atypia [3].
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Fig. 3 – Radial grayscale ultrasound image of the left breast demonstrate an oval, parallel, hyperechoic mass corresponding
to the mass seen on mammogram.

Fig. 4 – Power Doppler ultrasound image of the left breast demonstrate an oval, parallel, hyperechoic mass corresponding to
the mass seen on mammogram, without significant internal vascularity.

Malignant transformation may occur in up to 20% of phyllodes tumors, often within its stromal component. Of those
with malignant stromal differentiation, most display fibrosarcomatous components. Adipose stromal differentiation may
also occur, ranging from mature fat to liposarcomatous transformation [5–8]. However, pure lipomatous differentiation is

rare [9]. Powell and Rosen reported 14 cases of adipose differentiation, 13 of which were malignant [10].
One of the main differential considerations for a large,
rapidly growing mass is fibroadenoma. As opposed to phyllodes tumors, fibroadenomas are more likely to contain calcifications, are less likely to contain cystic spaces and are usually
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Fig. 5 – At 5× magnification, the lesion demonstrates a hypercellular stroma and distorted glandular elements with
extensive lipomatous differentiation.

Fig. 6 – At 20× magnification, compression of the glands into cleft-like spaces by the stromal overgrowth is seen. Mature
adipose tissue is present throughout the tumor.

uniform in stromal cellularity and distribution of stromal and
glandular elements [3]. Fibroadenomas also typically occur in
a younger subset of patients, with the mean age between 25
and 35. Overall, imaging alone cannot reliably distinguish fibroadenoma from phyllodes tumors. Additional differential
considerations include metaplastic carcinoma, primary breast
sarcoma, and periductal stromal sarcoma which are largely
distinguished histologically.

Given the extensive fat present within the mass on imaging, another differential diagnosis is a hamartoma, which is
a benign, well-circumscribed tumor composed of all components of breast tissue (fibrous, fibrocystic, and adipose tissue),
resulting in a “breast-within-a-breast" appearance on mammography. Histologically, disordered breast ducts and lobules
are present, unlike the phyllodes tumor which has epithelium
lined spaces and stromal overgrowth. Unlike the malignant

Radiology Case Reports 15 (2020) 2401–2405

2405

Fig. 7 – At 40× magnification, stromal cells are vesicular and pleomorphic with irregular nuclear contours and an increased
nuclear to cytoplasmic ratio. Numerous mitotic figures are present.

phyllodes tumor, hamartomas consist of bland appearing cells
without atypia [11]. Typically, fat-containing masses such as
hamartomas are considered benign on imaging. Given that
this mass was palpable and represented a mammographic
change from prior studies, further evaluation with biopsy was
warranted.
Management of both benign and malignant phyllodes tumors involves wide excision without axillary staging, with
subsequent clinical follow-up for 3 years.
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